Our Mission

We fight back against pediatric cancer by acting as an innovation incubator. We are here to fund leading edge research and give breakthrough ideas a start.

Jake's Story

When our son Jake was diagnosed with Hodgkin's lymphoma, he was in his senior year at Cherry Hill High School East. He battled both Hodgkins lymphoma and acute myeloid leukemia with an indomitable spirit that inspires us still.   Read more about Jake's story here.





Special thanks to our sponsors









Why Innovative Research

Cancer is the #1 cause of disease-related death in children and despite advances, most pediatric cancer treatments remain highly toxic and have not changed in decades. In this age of unprecedented technological and scientific promise, we can--and must--bring the power of innovation to pediatric cancer research.  Learn more here.


We’re funding innovative research to help find less toxic and more effective treatments for children and young adults with cancer.  For example, one of our grants supports the development of new “antibody conjugate” technology to more precisely attack cancer cells while leaving healthy cells unharmed. Another plans to harness the patient’s own immune system, genetically manipulating immune cells to recognize and kill cancer cells. You can read more about these as well as our other exciting research projects here.

Join the Fight!

Fight back against pediatric cancer while getting fit
(and amusing your friends)!
Need some motivation to
improve your fitness?
Have a family member you
want to motivate?
Do any of your friends deserve to be
challenged to the fitness max?


Sign up for Fight Back with Fitness. You challenge yourself to a personal fitness goal and raise funds by promising to stick with it. You get fit and kids get a better chance at beating cancer. Everyone wins.

Click here to find out more.



For more ways to help,

click here!

The Jake Wetchler Foundation for Innovative Pediatric Cancer Research is a 501(c)(3) tax-exempt organization and all donations are tax-deductible.